COMMUNIQUÉS West-GlobeNewswire

Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville
11/02/2019
Company Continues Long-Term, Strategic Relationship with Key Customer Recro Gainesville to be Exclusive Supplier of Ritalin LA ® and Focalin XR ® Capsules with “Total Revenue Per Capsule Economics” Expected to be [...]
Revive Closes Over 1.4 Million in Non-Brokered Private Placement
11/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]
Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
11/02/2019
New designation now includes all PNH patients WALTHAM Mass., and CRESTWOOD, Ky., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the [...]
RECORDATI: PRELIMINARY 2018 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +5.0%, EBITDA +9.8%, OPERATING INCOME +8.8%, NET INCOME +8.2%
11/02/2019
RECORDATI: PRELIMINARY 2018 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +5.0%, EBITDA +9.8%, OPERATING INCOME +8.8%, NET INCOME +8.2%. Consolidated revenues € 1,352.2 million, +5.0%. EBITDA (1) € [...]
Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva
11/02/2019
MONTREAL, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]
Clementia reçoit la désignation de « maladie pédiatrique rare » (Rare Pediatric Disease designation) de la FDA pour le palovarotène contre la fibrodysplasie ossifiante progressive
11/02/2019
MONTRÉAL, 11 févr. 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]
Achillion Appoints Brian Di Donato as Chief Financial Officer
11/02/2019
NEW HAVEN, Conn., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]
RadNet Signs a Definitive Agreement to Acquire the Imaging Operations of Kern Radiology, Further Expanding its Presence in Kern County and Bakersfield, California
11/02/2019
LOS ANGELES, Feb. 11, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has signed a [...]
Arrayit Corporation Nationwide Allergy Testing Network Doubles to More than 400 Healthcare Clinics
11/02/2019
Sunnyvale, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, reports that its nationwide allergy testing consortium has more than doubled in the past [...]
Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial
11/02/2019
Press Release 11 February 2019 Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial Immunicum AB (publ; IMMU.ST) announced today that the first patient has been treated in the Phase [...]
CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer
11/02/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer Cambridge, UK, XX February 2019 : CMR Surgical Ltd, the British company developing [...]
Tetra Bio-Pharma Announces Stock Option Grants
09/02/2019
ORLEANS, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the "Corporation") (TSX VENTURE: TBP) (OTB: TBPMF), announces today that it has granted, pursuant to the Company's stock option [...]
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
09/02/2019
NEWS RELEASE REGULATED INFORMATION HERSTAL, BELGIUM and IRVINE, CA - February 9, 2019 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received on February 7, 2019 the following [...]
MDxHealth (R): MDxHealth Déclaration de Transparence d'un Actionnaire
09/02/2019
COMMUNIQUE DE PRESSE INFORMATION REGLEMENTEE IRVINE, CA, et HERSTAL (BELGIQUE) - le 9 février 2019 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir reçu le 7 février 2019 la [...]
Adamas Announces New Employment Inducement Grant
09/02/2019
EMERYVILLE, Calif., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three new employees the [...]
Canada House Wellness Group Inc. Appoints Ernst & Young as Auditors
08/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) announced [...]
Auris Medical Announces Receipt of Nasdaq Notice
08/02/2019
Hearing Requested to Present Compliance Plan Zug, Switzerland, February 8, 2019 - Auris Medical Holding AG (Nasdaq: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet [...]
CORRECTING and REPLACING -- BLVD Centers Corporation Changes Name to Ventura Cannabis and Wellness Corp.
08/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, Feb. 08, 2019 (GLOBE NEWSWIRE) -- BLVD Centers [...]
Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019
08/02/2019
EAST RUTHERFORD, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage [...]

Pages